Jim Simons Rallybio Corp Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Rallybio Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 485,032 shares of RLYB stock, worth $242,516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
485,032
Previous 396,500
22.33%
Holding current value
$242,516
Previous $257,000
36.19%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RLYB
# of Institutions
50Shares Held
31.6MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.1 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$1.82 Million0.42% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$1.82 Million0.83% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$1.65 Million3.34% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$1.51 Million0.06% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $16.1M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...